| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 48.696 | 38.355 | 37.114 | - | - | 48.636 | 57.096 | 54.964 | 25.505 | 57.450 |
| Total Income - EUR | 48.696 | 38.355 | 37.114 | - | - | 48.636 | 57.096 | 54.964 | 25.505 | 57.450 |
| Total Expenses - EUR | 29.798 | 27.573 | 25.969 | - | - | 45.820 | 42.953 | 39.614 | 22.065 | 46.329 |
| Gross Profit/Loss - EUR | 18.898 | 10.782 | 11.145 | - | - | 2.816 | 14.143 | 15.350 | 3.440 | 11.121 |
| Net Profit/Loss - EUR | 17.437 | 10.399 | 10.774 | - | - | 2.278 | 13.573 | 14.800 | 3.218 | 10.558 |
| Employees | 1 | 2 | 2 | - | - | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Izoprest S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 9.256 | 9.161 | 9.006 | - | - | 2.160 | 1.313 | 494 | 493 | 490 |
| Current Assets | 31.531 | 13.676 | 15.104 | - | - | 36.260 | 37.192 | 30.549 | 23.075 | 34.518 |
| Inventories | 0 | 1.117 | 1.201 | - | - | 6.661 | 6.651 | 8.844 | 7.832 | 1.842 |
| Receivables | 18.687 | 10.782 | 7.045 | - | - | 16.250 | 14.295 | 13.073 | 4.586 | 3.722 |
| Cash | 12.845 | 1.777 | 6.858 | - | - | 13.349 | 16.246 | 8.631 | 10.657 | 28.954 |
| Shareholders Funds | 33.761 | 18.027 | 16.974 | - | - | 22.955 | 23.805 | 15.047 | 18.219 | 26.381 |
| Social Capital | 45 | 45 | 44 | - | - | 41 | 40 | 41 | 40 | 40 |
| Debts | 7.026 | 4.811 | 7.136 | - | - | 15.465 | 14.699 | 15.996 | 5.348 | 8.627 |
| Income in Advance | 0 | 0 | 0 | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4391 - 4391" | |||||||||
| CAEN Financial Year |
4391
|
|||||||||
Comments - Izoprest S.r.l.